Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter K Sand

Showing results (41-50 of 119) with videos related to

Pageof 12
Sort By:
Drugs & Aging|February 1, 2011
Once-daily trospium chloride 60 mg extended release in subjects with overactive bladder syndrome who use multiple concomitant medications: Post hoc analysis of pooled data from two randomized, placebo-controlled trialsPeter K Sand, Eric S Rovner, Jonathan H Watanabe, et al.
Obstetrics and Gynecology|July 20, 2011
Two unusual presentations of bladder diverticulaKelly E D Jirschele, Aimee Nguyen, Peter K Sand, et al.
Urology|March 18, 2008
Trospium 60 mg once daily (QD) for overactive bladder syndrome: results from a placebo-controlled interventional studyRoger R Dmochowski, Peter K Sand, Norman R Zinner, et al.
BJU International|February 16, 2010
Fesoterodine in patients with overactive bladder syndrome: can the severity of baseline urgency urinary incontinence predict dosing requirement?Linda Cardozo, Vik Khullar, Joseph T Wang, et al.
The Journal of Urology|May 6, 2004
Chronic pelvic actinomycosis following a bone anchored sling procedureYoram Abramov, Peter K Sand, Sanjay Gandhi, et al.
Family Practice|May 30, 2006
Perceptions and behaviours of women with bladder control problemsAnanias C Diokno, Peter K Sand, Scott Macdiarmid, et al.
International Urogynecology Journal and Pelvic Floor Dysfunction|October 18, 2005
Factors influencing the long-term success of periurethral collagen therapy in the officeSumana Koduri, Roger P Goldberg, Christina Kwon, et al.
Open Access Journal of Urology|November 8, 2013
Effect of baseline symptom severity on continence improvement mediated by oxybutynin chloride topical gelPeter K Sand, Scott A Macdiarmid, Heather Thomas, et al.
The Journal of Urology|March 5, 2013
Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group studyPeter K Sand, Roger R Dmochowski, Jyotsna Reddy, et al.
International Urogynecology Journal|December 1, 2018
Predictors of successful percutaneous tibial nerve stimulation (PTNS) in the treatment of overactive bladder syndromeGhazaleh Rostaminia, Cecilia Chang, Joseph B Pincus, et al.
Pageof 12

Showing results (41-50 of 119) with videos related to

Sort By:
Pageof 12
Drugs & Aging|February 1, 2011
Once-daily trospium chloride 60 mg extended release in subjects with overactive bladder syndrome who use multiple concomitant medications: Post hoc analysis of pooled data from two randomized, placebo-controlled trialsPeter K Sand, Eric S Rovner, Jonathan H Watanabe, et al.
Obstetrics and Gynecology|July 20, 2011
Two unusual presentations of bladder diverticulaKelly E D Jirschele, Aimee Nguyen, Peter K Sand, et al.
Urology|March 18, 2008
Trospium 60 mg once daily (QD) for overactive bladder syndrome: results from a placebo-controlled interventional studyRoger R Dmochowski, Peter K Sand, Norman R Zinner, et al.
BJU International|February 16, 2010
Fesoterodine in patients with overactive bladder syndrome: can the severity of baseline urgency urinary incontinence predict dosing requirement?Linda Cardozo, Vik Khullar, Joseph T Wang, et al.
The Journal of Urology|May 6, 2004
Chronic pelvic actinomycosis following a bone anchored sling procedureYoram Abramov, Peter K Sand, Sanjay Gandhi, et al.
Family Practice|May 30, 2006
Perceptions and behaviours of women with bladder control problemsAnanias C Diokno, Peter K Sand, Scott Macdiarmid, et al.
International Urogynecology Journal and Pelvic Floor Dysfunction|October 18, 2005
Factors influencing the long-term success of periurethral collagen therapy in the officeSumana Koduri, Roger P Goldberg, Christina Kwon, et al.
Open Access Journal of Urology|November 8, 2013
Effect of baseline symptom severity on continence improvement mediated by oxybutynin chloride topical gelPeter K Sand, Scott A Macdiarmid, Heather Thomas, et al.
The Journal of Urology|March 5, 2013
Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group studyPeter K Sand, Roger R Dmochowski, Jyotsna Reddy, et al.
International Urogynecology Journal|December 1, 2018
Predictors of successful percutaneous tibial nerve stimulation (PTNS) in the treatment of overactive bladder syndromeGhazaleh Rostaminia, Cecilia Chang, Joseph B Pincus, et al.
Pageof 12